KURA ONCOLOGY, INC.

Company

Kura Oncology, Inc.

Filed

February 12, 2021

Accession Number

0000902664-21-001240

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →